HAIER SMART HOME(SH:600690) 新浪财经·2026-03-30 10:15Core Viewpoint - Haier Group's subsidiary, Haier Jin控, issued a statement addressing false claims made by Yu Meiren Group's chairman, Yu Wenhong, regarding associations with Haier and misleading information about blood extraction and treatment services [2][3][4]. Group 1 - Yu Wenhong and Yu Meiren Group have no affiliation with Haier, and Yu Wenhong is not an employee of Haier [3]. - Haier Group and its subsidiaries do not engage in any blood-related services, including the rumored "blood microvesicle extraction and treatment" [4]. - Haier Jin控 is committed to protecting its brand and will pursue legal action against those who misuse its name and spread false information [5]. Group 2 - 盈康一生, launched by Haier Group in 2019, focuses on health sciences, clinical medicine, and biotechnology, with operations in 160 countries [5]. - Yu Meiren Group was established in Hong Kong in 2004, and its founder, Yu Wenhong, was previously exposed for lacking medical qualifications [5].